The United States Medicare program is forbidden, by law, from negotiating with pharmaceutical companies. This was part of a negotiation that was reached at the time that the government, under the leadership of George W. Bush, created Medicare Part D, to cover prescription benefits for Medicare recipients. The pharmaceutical industry was quite worried that government involvement in prescription coverage would lead to price-fixing. So they lobbied for language that would forbid such actions, and that would even limit the government from negotiating prices with Pharma companies.
The US public doesn’t support that policy. According to a Kaiser Family Foundation poll, the vast majority of people – Democrats, independents and Republicans – want to see such negotiations:
Now we will see who our elected representatives actually represent!
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.